Clinical Trial Update: Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder [NA]

View source ↗

Summary

A completed clinical trial evaluating closure of muscular ventricular septal defects using the AMPLATZER Muscular VSD Occluder; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Septal Defect

Drugs mentioned

• AMPLATZER Muscular VSD Occluder

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Septal Defects, Ventricular | NA | Status: COMPLETED | Results posted: 2019-06-28